EMBOBIO Medical is developing a natural embolization platform based on a conformable, material designed for controlled and reproducible occlusion. EMBOBIO® is in clinical evaluation with encouraging early results. FDA clearance is expected for early 2027, with expansion including EMBOBIO Micro® and MBA particles.